Почетна › Рак на бели дробови › Вирџинија › Arlington
Клинички испитувања за Рак на бели дробови во Arlington, VA
Една студија за Рак на бели дробови бара учесници на локација во или блиску до Arlington. Отворете ја за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
The Vanguard Study: Testing a New Way to Screen for Cancer
Се регрутираДобредојдени се здрави волонтери
- Inova Schar Cancer Institute, Fairfax · на 11 милји
- Inova Fair Oaks Hospital, Fairfax · на 11 милји
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Се регрутираФаза 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · на 5 милји
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Се регрутираФаза 2
- Virginia Cancer Specialists (VCS) ( Site 0408), Fairfax · на 11 милји
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Се регрутираФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of PHN-012 in Patients With Advanced Solid Tumors
Се регрутираФаза 1
- PHN-012-001 Site, Fairfax · на 11 милји
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Се регрутираФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 милји
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Се регрутираФаза 1
- Inova Schar Cancer Infusion Pharmacy, Fairfax · на 11 милји
- Inova Schar Cancer, Fairfax · на 11 милји
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Се регрутираФаза 2
- Research Site, Fairfax · на 11 милји
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Се регрутираФаза 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · на 11 милји
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Се регрутираФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 милји
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Се регрутираФаза 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · на 11 милји
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Се регрутираФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 милји
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Се регрутираФаза 1
- NEXT - Virginia, Fairfax · на 11 милји
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Се регрутираФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- USO-Virginia Cancer Specialists, PC, Fairfax · на 11 милји
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Се регрутираФаза 3
- USO - Virginia Cancer Specialists, Fairfax · на 11 милји
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Се регрутираФаза 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · на 11 милји
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Се регрутираФаза 1
- NEXT Oncology, Fairfax · на 11 милји
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Се регрутираФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 милји
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Се регрутираФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 милји
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Се регрутираФаза 3
- Inova Schar Cancer Institute, Fairfax · на 11 милји
- Inova Fair Oaks Hospital, Fairfax · на 11 милји
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Се регрутираФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 милји
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Се регрутираФаза 1
- Research Site, Fairfax · на 11 милји
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · на 5 милји
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Се регрутираФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 милји
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Се регрутираФаза 1/2
- Next Oncology Virginia, Fairfax · на 11 милји
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Се регрутираФаза 1/2
- NEXT Oncology, Fairfax · на 11 милји
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · на 5 милји
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · на 5 милји
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Се регрутираФаза 2
- Inova Fairfax Hospital, Fairfax · на 11 милји
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
Испитувања за Рак на бели дробови во други градови
- Houston, TX78 студии
- Boston, MA62 студии
- New York City, NY60 студии
- Los Angeles, CA45 студии
- Washington, DC41 студија
- Chicago, IL41 студија
- Baltimore, MD40 студии
- Nashville, TN40 студии
- St. Louis, MO39 студии
- Columbus, OH37 студии
- Philadelphia, PA36 студии
- Seattle, WA33 студии
Други студии во Arlington
- Рак на бели дробови со не-мали клетки104 студии
- Метастатски карцином53 студии
- Колоректален карцином52 студии
- Рак (сите типови)48 студии
- Рак на дојка47 студии
- Карцином на јајниците46 студии
- Рак на ендометриумот39 студии
- Карцином на панкреасот33 студии
- Сквамозноклеточен карцином на глава и врат26 студии
- Малоклеточен рак на бели дробови23 студии
- Рак на стомакот20 студии
- Трипл негативен рак на дојка20 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.